Iams Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$648K Buy
1,787
+255
+17% +$87.3K 0.2% 131
2026
Q1
$539K Sell
1,532
-2,797
-65% -$997K 0.19% 136
2025
Q4
$1.42M Buy
4,329
+2,590
+149% +$822K 0.51% 63
2025
Q3
$491K Sell
1,739
-1,511
-46% -$438K 0.2% 124
2025
Q2
$908K Sell
3,250
-5,200
-62% -$1.47M 0.42% 72
2025
Q1
$2.63M Buy
8,450
+5,228
+162% +$1.54M 1.21% 19
2024
Q4
$840K Buy
3,222
+685
+27% +$203K 0.38% 75
2024
Q3
$818K Buy
2,537
+72
+3% +$23.6K 0.4% 73
2024
Q2
$770K Sell
2,465
-1,214
-33% -$357K 0.42% 70
2024
Q1
$1.02M Sell
3,679
-453
-11% -$133K 0.62% 57
2023
Q4
$1.19M Sell
4,132
-1,453
-26% -$396K 0.77% 44
2023
Q3
$1.5M Buy
+5,585
New +$1.39M 1.04% 32
2023
Q2
Sell
-3,774
Closed -$876K 134
2023
Q1
$910K Buy
3,774
+1,568
+71% +$385K 0.76% 46
2022
Q4
$579K Buy
+2,206
New +$591K 0.59% 55

Other funds holding AMGN

Iams Wealth Management's AMGN Position: Q2 2026 in Review

Iams Wealth Management increased its Amgen (AMGN) stake by 17% in Q2 2026, buying an estimated $87.3K and bringing the position to 1,787 shares worth $648K. The position accounts for 0.2% of the portfolio, ranked #131.

Iams Wealth Management first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.63M in Q1 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Iams Wealth Management held 1,787 shares of Amgen worth $648K as of Q2 2026.
  • Iams Wealth Management bought 255 Amgen shares in Q2 2026, an estimated $87.3K.
  • Amgen made up 0.2% of Iams Wealth Management's portfolio in Q2 2026, its #131 holding.
  • Iams Wealth Management first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Iams Wealth Management's Amgen position peaked at $2.63M in Q1 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Iams Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.